{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:46:52Z","timestamp":1793249212642,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Differentiating malignant pleural mesothelioma from benign reactive mesothelial processes can be quite challenging. Ancillary tests such as BRCA1-associated protein 1 (BAP1) immunohistochemistry and p16 fluorescence in situ hybridization (FISH) are helpful tools to aid in this distinction. Immunohistochemistry for methylthioadenosine phosphorylase (MTAP) has recently been proposed as an effective surrogate marker for p16 FISH and is an attractive alternative test due to shorter turnaround time. There are little data regarding the specificity of MTAP loss for mesothelioma or whether it may be useful to distinguish mesothelioma from the most common entity in the differential diagnosis, sarcomatoid carcinoma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We studied well-characterized cases of sarcomatoid carcinoma (n\u2005=\u200534) and sarcomatoid mesothelioma (n\u2005=\u200562), which were stained for MTAP (clone 2G4) and BAP1 (clone C-4).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Loss of MTAP expression was observed in 17 (50%) of 34 pulmonary sarcomatoid carcinomas; BAP1 expression was retained in all of the cases in which it was performed (n\u2005=\u200531). MTAP expression was lost in 38 (61%) of 62 sarcomatoid mesotheliomas; BAP1 was lost in 6 (10%) of 62. In the six cases with BAP1 loss, five also had loss of MTAP, while MTAP expression was retained in one.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Loss of MTAP expression by immunohistochemistry is common in pulmonary sarcomatoid carcinoma, as it is present in half of cases. This rate is similar to what is observed in sarcomatoid mesothelioma (61%). Therefore, this stain is not useful to distinguish between these two malignancies. MTAP loss is more common than BAP1 loss in the setting of sarcomatoid mesothelioma (61% vs 10%, respectively).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqab091","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T19:32:30Z","timestamp":1619465550000},"page":"33-39","source":"Crossref","is-referenced-by-count":16,"title":["Loss of Methylthioadenosine Phosphorylase by Immunohistochemistry Is Common in Pulmonary Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma"],"prefix":"10.1093","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-2346","authenticated-orcid":false,"given":"Simone","family":"Terra","sequence":"first","affiliation":[{"name":"Division of Anatomic Pathology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C","family":"Roden","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhee S","family":"Yi","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Aubry","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Boland","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"2023112010223655300_CIT0001","volume-title":"WHO Classification of Tumours of Lung, Pleura, Thymus and Heart.","author":"Travis","year":"2015","edition":"4th ed"},{"key":"2023112010223655300_CIT0002","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med."},{"key":"2023112010223655300_CIT0003","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet."},{"key":"2023112010223655300_CIT0004","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"2023112010223655300_CIT0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene."},{"key":"2023112010223655300_CIT0006","first-page":"5547","article-title":"p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma","volume":"54","author":"Cheng","year":"1994","journal-title":"Cancer Res."},{"key":"2023112010223655300_CIT0007","doi-asserted-by":"crossref","DOI":"10.1111\/his.14324","article-title":"Correlation of MTAP protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma","author":"Chapel","year":"2021","journal-title":"Histopathology"},{"key":"2023112010223655300_CIT0008","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod Pathol."},{"key":"2023112010223655300_CIT0009","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2559.2009.03298.x","article-title":"Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"54","author":"Takeshima","year":"2009","journal-title":"Histopathology."},{"key":"2023112010223655300_CIT0010","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.humpath.2013.09.005","article-title":"Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma\u2014sensitivity of TTF-1 is superior to napsin","volume":"45","author":"Terra","year":"2014","journal-title":"Hum Pathol."},{"key":"2023112010223655300_CIT0011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00000478-200303000-00004","article-title":"Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases","volume":"27","author":"Rossi","year":"2003","journal-title":"Am J Surg Pathol."},{"key":"2023112010223655300_CIT0012","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/modpathol.2016.181","article-title":"MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"30","author":"Amatya","year":"2017","journal-title":"Mod Pathol."},{"key":"2023112010223655300_CIT0013","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/PAS.0000000000000825","article-title":"GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung","volume":"41","author":"Berg","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"2023112010223655300_CIT0014","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5858\/arpa.2019-0647-OA","article-title":"Utility of immunohistochemistry for MUC4 and GATA3 to aid in the distinction of pleural sarcomatoid mesothelioma from pulmonary sarcomatoid carcinoma","volume":"145","author":"Terra","year":"2021","journal-title":"Arch Pathol Lab Med."},{"key":"2023112010223655300_CIT0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2020.04.005","article-title":"Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4","volume":"100","author":"Naso","year":"2020","journal-title":"Hum Pathol."},{"key":"2023112010223655300_CIT0016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2008.04.019","article-title":"Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non\u2013small cell lung carcinoma","volume":"63","author":"Watanabe","year":"2009","journal-title":"Lung Cancer."},{"key":"2023112010223655300_CIT0017","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat Genet."},{"key":"2023112010223655300_CIT0018","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.humpath.2016.10.005","article-title":"Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non\u2013small cell lung cancer","volume":"60","author":"Owen","year":"2017","journal-title":"Hum Pathol."},{"key":"2023112010223655300_CIT0019","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ejso.2014.04.017","article-title":"MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients","volume":"40","author":"Su","year":"2014","journal-title":"Eur J Surg Oncol."},{"key":"2023112010223655300_CIT0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cncy.21928","article-title":"A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma","volume":"126","author":"Kinoshita","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"2023112010223655300_CIT0021","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2018.09.019","article-title":"A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","volume":"125","author":"Kinoshita","year":"2018","journal-title":"Lung Cancer."},{"key":"2023112010223655300_CIT0022","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer."},{"key":"2023112010223655300_CIT0023","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cncy.22221","article-title":"Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"128","author":"Berg","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"2023112010223655300_CIT0024","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/modpathol.2016.89","article-title":"Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases","volume":"29","author":"Terra","year":"2016","journal-title":"Mod Pathol."},{"key":"2023112010223655300_CIT0025","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1073\/pnas.81.9.2665","article-title":"Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization","volume":"81","author":"Carrera","year":"1984","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2023112010223655300_CIT0026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-291X(78)90393-5","article-title":"Methylthioadenosine nucleoside phosphorylase deficiency in methylthio-dependent cancer cells","volume":"83","author":"Toohey","year":"1978","journal-title":"Biochem Biophys Res Commun."},{"key":"2023112010223655300_CIT0027","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1073\/pnas.78.2.1219","article-title":"Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme","volume":"78","author":"Kamatani","year":"1981","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2023112010223655300_CIT0028","first-page":"6639","article-title":"Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a\/ARF), acts as a tumor suppressor in a breast cancer cell line","volume":"62","author":"Christopher","year":"2002","journal-title":"Cancer Res."},{"key":"2023112010223655300_CIT0029","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ajpath.2010.11.059","article-title":"Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5\u2032-deoxy-5\u2032-methylthioadenosine (MTA)","volume":"178","author":"Kirovski","year":"2011","journal-title":"Am J Pathol."},{"key":"2023112010223655300_CIT0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0165-4608(95)00157-3","article-title":"Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines","volume":"86","author":"Zhang","year":"1996","journal-title":"Cancer Genet Cytogenet."},{"key":"2023112010223655300_CIT0031","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1038\/sj.onc.1203942","article-title":"A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer","volume":"19","author":"Schmid","year":"2000","journal-title":"Oncogene."},{"key":"2023112010223655300_CIT0032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng0994-27","article-title":"Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma","volume":"8","author":"Caldas","year":"1994","journal-title":"Nat Genet."},{"key":"2023112010223655300_CIT0033","first-page":"5804","article-title":"CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines","volume":"54","author":"He","year":"1994","journal-title":"Cancer Res."},{"key":"2023112010223655300_CIT0034","first-page":"3737","article-title":"The MTS1 gene is frequently mutated in primary human esophageal tumors","volume":"9","author":"Zhou","year":"1994","journal-title":"Oncogene."},{"key":"2023112010223655300_CIT0035","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1182\/blood.V84.12.4038.bloodjournal84124038","article-title":"Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias","volume":"84","author":"Hebert","year":"1994","journal-title":"Blood."},{"key":"2023112010223655300_CIT0036","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/87.10.756","article-title":"Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines","volume":"87","author":"Kelley","year":"1995","journal-title":"J Natl Cancer Inst."},{"key":"2023112010223655300_CIT0037","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/JTO.0b013e3182a46c0c","article-title":"CDKN2A\/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer","volume":"8","author":"Tam","year":"2013","journal-title":"J Thorac Oncol."},{"key":"2023112010223655300_CIT0038","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/sj.onc.1202205","article-title":"Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non\u2013small cell lung cancers (NSCLC)","volume":"17","author":"Schmid","year":"1998","journal-title":"Oncogene."},{"key":"2023112010223655300_CIT0039","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V60.6.1387.1387","article-title":"Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo","volume":"60","author":"Kamatani","year":"1982","journal-title":"Blood."},{"key":"2023112010223655300_CIT0040","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/80.14.1159","article-title":"Cytogenetic analysis of melanocytes from premalignant nevi and melanomas","volume":"80","author":"Cowan","year":"1988","journal-title":"J Natl Cancer Inst."},{"key":"2023112010223655300_CIT0041","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)63695-4","article-title":"Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma","volume":"163","author":"Behrmann","year":"2003","journal-title":"Am J Pathol."},{"key":"2023112010223655300_CIT0042","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1158\/1078-0432.CCR-04-0972","article-title":"Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer","volume":"10","author":"Subhi","year":"2004","journal-title":"Clin Cancer Res."},{"key":"2023112010223655300_CIT0043","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4161\/cbt.4.1.1380","article-title":"Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy","volume":"4","author":"Hustinx","year":"2005","journal-title":"Cancer Biol Ther."},{"key":"2023112010223655300_CIT0044","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1158\/1078-0432.CCR-09-1511","article-title":"Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors","volume":"15","author":"Huang","year":"2009","journal-title":"Clin Cancer Res."},{"key":"2023112010223655300_CIT0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41598-020-57812-2","article-title":"MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab","volume":"10","author":"Jing","year":"2020","journal-title":"Sci Rep."},{"key":"2023112010223655300_CIT0046","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science."},{"key":"2023112010223655300_CIT0047","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet."},{"key":"2023112010223655300_CIT0048","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet."},{"key":"2023112010223655300_CIT0049","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet."},{"key":"2023112010223655300_CIT0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/path.5551","article-title":"Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma","volume":"253","author":"De Rienzo","year":"2021","journal-title":"J Pathol."},{"key":"2023112010223655300_CIT0051","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41379-018-0022-x","article-title":"MUC4 staining in sarcomatoid carcinomas","volume":"32","author":"Berg","year":"2019","journal-title":"Mod Pathol."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/157\/1\/33\/53586134\/aqab091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/157\/1\/33\/53586134\/aqab091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:23:09Z","timestamp":1700475789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/157\/1\/33\/6360386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,31]]},"published-print":{"date-parts":[[2022,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqab091","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,31]]}}}